# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery...
Cantor Fitzgerald analyst Ross Osborn initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Overweight rating and announce...
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $11 pr...
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by...
Lake Street analyst Brooks O'Neil initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Buy rating and announces Price...
Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $13 to $14.